Premium Industrial News

Japan's Pharma Majors Invest $525 Million in API-Related Projects

Japan's Pharma Majors Invest $525 Million in API-Related Projects

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 110 Words
Attachment: Japan API 1121

KOFU, JAPAN--November 5, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Many Japanese pharmaceutical majors are expanding their active pharmaceutical ingredient (API) production facilities to produce new COVID-19 vaccines. In addition, they are at work on more typical maintenance, plant-expansion, equipment-upgrade and equipment-replacement projects.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?